Medicija - Company finances
|
EUR
|
2022
From: 2022-08-26
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | - | - | 227,787 | 590,571 |
| Profit before tax | - | - | - | - |
| Net profit | -688 | -39,237 | -43,955 | -133,421 |
| Equity | 2,312 | -36,926 | -80,881 | 3,785,698 |
| Liabilities | 24 | 2,720,850 | 4,552,792 | 4,026,693 |
| Non-current assets | 0 | 1,811,716 | 4,287,149 | 7,444,535 |
| Current assets | 2,366 | 872,222 | 184,727 | 367,447 |
| Total assets | 2,366 | 2,683,938 | 4,471,876 | 7,811,982 |
|
Taxes paid
|
||||
| STI taxes | - | 18,267 | 61,076 | 56,767 |
| Social insurance contributions | - | - | 3,670 | 84,011 |
|
Financial indicators
|
||||
| Revenue change y/y | - | - | - | +159.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -29.1% | -1.5% | -1.0% | -1.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -29.8% | - | - | -3.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | -19.3% | -22.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | - | - | 1.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 73,878 | 72,315 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Medicija - Social security debts
The company had no debts to Sodra
Medicija - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2024-10-16 | 2024-10-16 | 51.94 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Medicija, UAB (code 306137610) is a Private Limited Liability Company operating in other human health activities n.e.c. In the latest financial year, 2025, the company generated revenue of €590.6K, up 159.3% year on year, but remained loss-making with a net loss of €133.4K and a profit margin of -22.6%. The 2024 figure also shows a loss of €44.0K on revenue of €227.8K, while 2023 ended with a net loss of €39.2K and negative equity, indicating a difficult prior base before the stronger 2025 sales growth. At the end of 2025, total assets reached €7.81M, supported by equity of €3.79M and liabilities of €4.03M. Long-term assets accounted for most of the balance sheet at €7.44M, while short-term assets were €367.4K. Key ratios for 2025 show modest leverage and weak operating efficiency, with ROE at -3.5%, ROA at -1.7%, debt-to-equity at 1.06, and asset turnover at 0.08x. Revenue per employee was €73.8K, while profit per employee was negative.